Patent · US Active

Use of KGF in the treatment of menopausal disorders

US9827292B2 · kind B2 · utility

0Cited by

1References

6Claims

0Family size

Assignee

UNIVERSITÀ DEGLI STUDI DI ROMA “LA SAPIENZA” · IT

Inventors

Cinzia Marchese · Roma, IT
Simona M. Ceccarelli · Basel, CH
Antonio Angeloni · Roma, IT

Key dates

Filing date	Aug 7, 2013
Grant date	Nov 28, 2017
Priority date	—
Expiry date	Aug 7, 2033

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P15/02
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to the use of keratinocyte growth factor (KGF/FGF7) and pharmaceutical compositions thereof in the treatment of vaginal atrophy, dysuria, vaginal pain and/or vaginal dryness induced by a post-menopausal state, by surgical intervention, by illness and/or by chemotherapy or radiotherapy treatments.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.